C
rohn's disease is a chronic inflammatory bowel disease (IBD) characterized by the presence of inflammation, abscesses, fistulas, and strictures that can affect any part of the gastrointestinal tract, being more frequent in the distal ileum. Crohn's disease can cause intestinal obstruction and perforation and seems to increase the risk of cancer in the affected areas. 1 Even if the recent introduction of biological immunosuppressant anti-tumor necrosis factor drugs has improved the medical control of this disease, 2 80% of the patients will need at least 1 surgical intervention during their life. 3, 4 Many specialized proteins and interleukins (ILs) (IL1b, IL6, and IL8) produced by lymphocytes and macrophages are involved in the immune response and pathogenesis of IBDs and could be a target for their treatment. 5 It has been previously demonstrated that an increased local concentration in the intestinal wall of IL10 could diminish intestinal inflammation and complications in these patients. 6 IL-10 is an antiinflammatory class 2 cytokine encoded by the IL10 gene with pleiotropic immunomodulatory effects. 7 IL10 diminishes the expression of Th1 cytokines, major histocompatibility complex class II antigens, and the costimulatory molecules in macrophages; suppresses the antigens presentation by specialized cells; and inhibits the expression of proinflammatory cytokines as IFNg, IL2, IL3, and granulocyte-macrophage colony-stimulating factor. 7 IL10 also transforms naive lymphocytes (CD4 + CD25 2 Foxp3 2 ) in Treg cells (regulatory T cells), 8 which are mainly responsible for immunosuppressive response and can inhibit different proinflammatory cell populations, including CD4 + T cells, CD8 + T cells, natural killer T cells, dendritic cells, monocytes/macrophages, B cells, and natural killer cells. 9 It has already been shown how IL10-deficient mice spontaneously develop chronic colitis due to an aberrant immune response to commensal bacteria. 10 Therefore, IL10 may play an important role in controlling Crohn's disease pathologic immune response. However, systemic administration of recombinant IL10 cytokine has pleiotropic effects and short half-life that reduces its benefit/risk relation. 11 IL10 gene transfection to intestinal wall could mediate the local persistent release of protein with direct effect in the target area but with low systemic effects due to its further dilution in the bloodstream.
So far, many methods have been used in preclinical studies to transfer genes to the gastrointestinal tract, confirming the interest of gene therapy for the treatment of inflammatory diseases, 12, 13 colorectal cancer, 14 and cystic fibrosis symptoms. 15 Gastrointestinal tract is easily accessed per oral or rectal via, and many studies have described the enteric via for intestinal gene therapy. However, the physiologic barriers present in the intestinal wall limit the efficacy of such an approach. 15 In hydrodynamic vascular gene transfer, a DNA solution is injected in the vessels of the target organ. The volume and flow variations induce changes in cell membrane permeability, allowing the access of DNA to the cells. 16, 17 Such method has previously proved its efficacy in heart preclinic and liver "ex vivo" models. [18] [19] [20] The aim of this work is to evaluate the efficacy of hydrodynamic venous IL10 gene delivery to "ex vivo" human colon segments and to determine its potential interest in Crohn's disease treatment based on the molecular evaluation of gene delivery, messenger RNA expression, and protein production in the tissue. The vascular anatomical characteristics of colon segments resected from patients with IBD, following the habitual clinical practice performed in our Hospital, limit the hydrodynamic injection procedure in these segments "ex vivo" because of the resection proximity to the bowel and, therefore, would be difficult to evaluate gene transfer efficacy. Thus, we used intestinal resection for cancer because the vessels are divided close to the origin for oncologic reasons and are therefore of big diameter. This fact allows more easily the injection of the volume of solution needed for transfection experiments. For opportunity reasons, we also evaluated the efficiency of gene transfer and expression in tumor tissues to define the potential role of hydrodynamic gene transfer strategy to treat cancer in future studies. It is actually not possible for us to obtain completely healthy (without tumor) human colon segments, with an intact vascular pedicle for research purposes.
With the aim of standardizing the presentation of data, we refer the results to a normalized cell because we consider it easier to manage than using arbitrary magnitudes, being aware that there are many different types of cells, with different transcription and translation rates.
MATERIALS AND METHODS

Colon Segments
Human colon segments measuring approximately 25 cm long (range 15-29 cm) were obtained from surgical resections performed for tumor resections. The colon resection was performed using a standard technique, with radical mesocolon excision and high-tie of the vascular pedicle. 21 The number of segments used in the human IL10 (hIL10) molecular studies was 19, corresponding to 19 different patients. From these 19 segments, 6 were used as controls without being transfected, and the other 13 were injected with the gene solution. The distance from the vessels to the distal edge of the specimen was divided into 3 equal parts, and the 3 zones were defined as A (closest to the vessels), B and C (farthest from the vessels) (Fig. 1) . Finally, for ultrastructural studies to observe the tissue distribution of gold nanoparticles, 1 additional human colon segment was used. The Declaration of Helsinki protocols were followed, and patients gave their written informed consent. This research was approved by the clinical research ethics Committee of the University Hospital La Fe, Valencia (Spain).
Reagents
Tissue extraction of DNA and RNA was performed using the commercial Maxwell 16 Mouse Tail DNA Purification Kit and Maxwell 16 LEV simplyRNA Tissue Kit, respectively, from Promega (Barcelona, Spain). The specific kit for hIL10 TaqMan quantitative PCR was obtained from Life Technologies (cat no. Hs00961622_m; Carlsbad, CA). The anti-hIL10 antibodies enzyme-linked immunosorbent assay (ELISA) kit was obtained from BD Biosciences (cat. no. 555157; San Jose, CA). The plasmid p2F-hIL10 (6.86 Kb), containing the human IL10 protein complementary DNA (cDNA) (intronless ORF from the ATG to the stop codon, size: 537 bp), was purchased from Invivogen based on pVITRO2 (Invivogen, Toulouse, France) backbone and driven by ferritin FerH (heavy chain) promoter, constructed by cloning hIL10 into the HindIII site. The total protein content of each sample was quantified using the NanoOrange Protein Quantitation Kit (Life Technologies).
"Ex Vivo" Gene Transfer to Colon Segment
Human colon segments obtained from surgical resection were immediately transported under humid and sterile box conditions to the laboratory, and all experimental processing were completed in less than 0.5 hours, using sterile solutions and aseptic conditions. The specimen extremities were clamped to avoid vascular leak during gene injection. A flexible 8F introducer (used as catheter), filled with saline solution, was then placed by the surgeon (MF) into the main vein of the vascular pedicle. After catheter fixation, 5 mL of iodinated radiological contrast were injected to confirm the correct positioning of the catheter and the absence of vascular leak (Fig. 1) . The contrast injection (less than 5 mL) was always performed at low speed with low pressure. The visualization of a well-defined vascular tree was required before performing the hydrodynamic gene solution injection. For gene transfer study, 50 mL of a saline solution bearing the hIL10 plasmid (20 mg/mL) was injected at 20 mL/s flow rate (n ¼ 13). Results were compared with those obtained from control (nontransfected) colon segments (n ¼ 6). The catheter was removed 5 minutes after the injection (time to permit plasmid entrance into the cells). Then, tissue samples were obtained from 3 different areas (A, B, and C) according to their proximity to the injection focus, zone A being the closest to the injection site and C the farthest (Fig. 1) . Tumor samples were also collected (T). Tissue samples of 1 mm in thickness from all these areas were subsequently cut under sterile conditions and cultured in Dulbecco's modified Eagle's medium and 5% CO2 atmosphere. Samples were removed from culture 0.15 days (3-4 h), 1, 2, and 4 days after transfection and processed for molecular analysis to evaluate the efficiency of gene delivery and the results of hIL10 expression. Data were expressed as DNA, RNA, and protein copies per cell, considering that a standard human cell contains a total amount of 6.6 pg DNA, 20 pg RNA, and 500 pg protein. 22 For morphological studies, the same procedure was performed, but injecting a solution containing 4 and 15 nm (in diameter) gold nanoparticles (1.8 · 10 12 Au particles of each diameter per milliliter) for further observation under transmission electron microscope.
hIL10 ELISA
Tissue samples representing the whole colon wall were cut into small pieces and cultured in Dulbecco's modified Eagle's medium at 378C and 5% CO2 atmosphere. After 0.15 days (3-4 h after injection), 1, 2, and 4 days, these tissue samples were removed from the culture and homogenized in a homogenization buffer (Promega) with an Ultra-Turrax homogenizer (Hielscher Ultrasonics GmbH, Teltow, Germany). Total protein amount was quantified using the NanoOrange Protein Quantitation Kit (Life Technologies) following the manufacturer's instructions. For human IL10 detection, BD OptEIA Human IL10 ELISA Set commercial kit (Beckton and Dickinson Biosciences, Madrid, Spain) was used following the manufacturer's instructions. In brief, capture antibody was added to plate wells and then the plate was incubated overnight. Afterward, the plate was brought under several washes and then blocked. Subsequently, after several more washes, samples and standard curve were added and incubated for 2 hours under room temperature conditions. Then, plate was washed again, and the solution containing the detection antibody was added. After incubation and washing, detection solution was added and plate remained in incubation under dark conditions. Finally, reaction was stopped and absorbance measured at 450 nm. The standard curve was prepared using the purified hIL10 protein. In our hands, it was a lineal standard curve from 7.8 to 500 pg/mL with a correlation coefficient .0.99. Results were determined in pg/ml and were transformed to number of molecules per cell. For this transformation, we used the molecular weight of the protein (20 kDa [NCBI protein database: http:// www.ncbi.nlm.nih.gov/protein/AAK38162.1]) and total protein amount per normalized cell in each individual sample.
Quantitative PCR and Reverse Transcription PCR
Tissue samples from the above-mentioned territories, representing the whole colon wall, were cut into small pieces and homogenized in a homogenization buffer (Promega, Barcelona, Spain) with an Ultra-Turrax homogenizer (Hielscher Ultrasonics GmbH). Further purifications with the Maxwell RNA and DNA purification from tissue kits (Promega) were performed before spectrophotometric quantification. RNA retrotranscription to cDNA was performed using 1 mg total RNA (DNA free), random hexamers and a High Capacity cDNA Archive Kit (Applied Biosystems). For quantitative real-time quantitative PCR, TaqMan Universal Master Mix II (Applied Biosystems, Foster City, CA) was used according to the manufacturer's instructions. The specific oligonucleotides for human IL-10 used were a premixed TaqMan kit from Life Technologies, cat no. Hs00961622_m. Quantitative data were calculated as the number of DNA and RNA copies on a regression curve which was plotted using the injected plasmid containing the hIL10 gene. The curve was prepared with a known concentration of hIL10 plasmid and serial 1/ 10 dilutions. Linearity of the standard curve was from 10 3 to 10 7 copies with a correlation coefficient .0.95. In these experiments, standard curve sensitivity permitted to determine down to 5 · 10 23 DNA copies or 2 · 10 21 cDNA copies per cell.
Molecular Data Presentation
Quantitative data are expressed as copies of each molecular species per normalized human cell as previously described 20 (DNA: 6.6 pg; RNA: 20 pg; Protein: 0.5 ng), resulting in the following indexes:
1. Index of gene delivery: (no. hAAT DNA copies/pg of total DNA)*6.6 2. Index of gene transcription: (no. hAAT messenger RNA copies/pg of total RNA)*20 3. Index of gene translation: (no. hAAT protein molecules/pg of total protein)*500
To evaluate the goodness of the procedure and the bioavailability of the DNA delivered to be transcribed and translated, we also calculated the activity of transcription and the apparent efficacy of expression: 
Gold Nanoparticle Synthesis
All chemicals were purchased from Sigma-Aldrich (Madrid, Spain) and used as received, without further purification. Gold nanoparticles were synthesized following a modification of the Turkevich method. 23 Typically, 0.4 g of HAuCl4.3H2O was dissolved in 90 mL of water in a 2-neck round flask (1.3 mM HAuCl4). The resulting solution was heated to boiling and refluxed. Then, 9 mL of a 47.2 mM sodium citrate solution (0.125 g sodium citrate in 9 mL water) was preheated and quickly added. The solution turned from yellow to black and then to deep red. After the color changed, the solution was refluxed for 20 minutes. Then, the heater was turned off and the solution was stirred until it reached room temperature. The resulting solution was diluted with water to a final volume of 500 mL. Gold nanoparticles were characterized by transmission electron microscopy (Jeol 1010, Tokyo, Japan). The average diameter and the size distribution of the gold nanoparticles were determined from transmission electron microscopy images by counting at least 300 nanoparticles using Image Pro Plus software from Media Cybernetics (Bethesda, MD).
Electron Microscopy
Human right colon segment (n ¼ 1) was hydrodynamically injected (volume 50 mL) through the catheter placed in the ileocolic vein with a buffered solution of 2.5% glutaraldehyde containing 10 12 gold particles per milliliter, to study the colon distribution of 4 and 15 nm gold nanoparticles after injection. Then, small tissue pieces from different colon areas were removed and immersed in phosphate Sørensen buffer (pH 7.4) solution containing 2.5% glutaraldehyde. For transmission electron microscopy, multiple 1 mm 3 pieces of the colon wall were routinely processed and embedded in Epoxy resin. Ultrathin sections stained with uranyl acetate were examined under a Jeol JEM-1010 electron microscope. It must be underlined that, to better identify the gold nanoparticles in tissues, sections were not stained with lead, as usually. Although this reduces the definition of tissue anatomical features, it facilitates the observation of nanoparticles and circumvents the low contrast that they present within the tissue.
Statistical Analysis
A mixed model of linear regression using repeated measures with random effect of subjects was performed for indexes of DNA delivery, RNA transcription, and protein translation. Data were compared between the 3 perfusion zones (A, B, and C), between treated and control tissues and between treated healthy tissue and treated tumor tissues. For intrinsic activity of transcription and the apparent efficacy of expression, mixed linear regression statistical analyses were used, too. Interaction between tissue type (control, healthy tissue treated, and tumor tissue treated) and time has been considered. Value variable was converted to logarithm to concentrate the data and diminish their variability. Only P values lower than 0.05 were considered as significant. Statistical analyses were performed by a professional biostatistician (Biostatistics Unit, IIS La Fe) using version 3.3.1 of R-studio software (Boston, MA) and nlme package.
RESULTS
Effect of Hydrodynamic Injection on IL10 Expression
Two colon segments were transfected with the tracer eGFP gene under the same experimental conditions as sample specimens. We determined the indexes of hIL10 gene transcription and translation using the same procedures (quantitative real-time PCR and ELISA) than in the hIL10-treated colon segments. The hydrodynamic injection with eGFP gene increases the levels of hIL10 RNA in the colon tissue (2-fold), being lower than the hIL10-treated segments but without statistical significance (P ¼ 0.191). However, this effect was not observed in the final expression of protein, in which hIL10 transfection mediated significantly higher (P , 0.001) index of protein translation than that observed with eGFP controls (hIL10 protein undetectable).
Index of hIL10 DNA Delivery
In all cases, hIL10 DNA levels were higher in treated tissues than in controls (P , 0.001) (Fig. 2, right) . The levels of hIL10 DNA were similar in the 3 zones (A, B, and C), without statistically significant differences among them (P ¼ 0.59) (Fig. 2,  left) . The time variable has shown to be statistically significant (P , 0.001), with a progressive decrease of DNA quantity in all experimental cases. When comparing the levels of hIL10 DNA between healthy and cancer tissues, significant (P ¼ 0.013) differences were found. In cancer tissues, hIL10 DNA levels do not decrease as rapid as in healthy tissues along time.
Index of hIL10 RNA Transcription
The amount of hIL10 RNA was significantly increased in treated tissues compared with controls (P ¼ 0.001) and in cancer tissues compared with healthy tissues (P ¼ 0.01) (Fig. 3, right) .
When considering the copies/cell of hIL10 RNA, no differences were observed between different perfusion zones (P ¼ 0.58) (Fig. 3, left) , nor over time (P ¼ 0.18) (Fig. 3 lower) . In cancer tissues, the number of copies/cell was greater on the fourth day (P ¼ 0.047).
Index of hIL10 Protein Translation
The indexes of protein hIL10 translation in treated groups are much higher (P , 0.001) than the basal production determined in controls, being statistically different (Fig. 4, right) . The index of translation was not statistically different between different zones of the colon (P ¼ 0.83) (Fig. 4, left) , nor between healthy tissues and tumors (P ¼ 0.35) (Fig. 4, right) . The onset of protein expression is established during the first hours and is maintained during, at least, 4 days (Fig. 4, lower) . In this sense, the time variable has not shown to be determinant.
Activity of Transcription
The activity of transcription could be described as the transcription/delivery indexes ratio and measures the availability of the delivered DNA to be transcribed. Table 1 compares the activities of transcription among control nontransfected tissues, different areas of healthy treated tissues, and tumor-treated tissues. The activity of transcription was always higher in treated tissues. However, no significant differences (P ¼ 0.11) were observed between healthy treated tissues and controls nor between tumor-treated tissues and controls, P ¼ 0.75. In tumor, although SD was greater, more effective transcription was observed at days 2 and 4 than in healthy treated tissues. When considering the interaction of tissue type and time, it was observed that the behavior of transcription activity over time was significantly (P , 0.001) different between healthy treated tissues and controls, being stable in control and increasing in healthy treated tissues. Such difference was not observed in tumor-treated tissues (P ¼ 0.08).
Apparent Efficacy of Expression
The apparent efficacy of expression measures how many copies of IL10 protein are being produced by each copy of the IL10 delivered gene. Thus, it is described as the ratio of the indexes of gene translation and gene delivery. This efficacy resulted lower in controls during the entire period of sampling. apparent efficacy of gene expression among control nontransfected tissues, different areas of healthy treated tissues, and tumor-treated tissues. A significant difference (P ¼ 0.01) between healthy treated tissues and controls was observed. Such significance was not found between tumor-treated tissues and controls, P ¼ 0.19. In tumor, although SD was greater, more effective expression was observed at days 1 and 2 compared with healthy treated tissues. When considering the interaction of tissue type and time, it was observed that the evolution of expression apparent efficacy along time was significantly different between healthy treated tissues and controls (P ¼ 0.007) and between tumor-treated tissues and controls (P ¼ 0.038). Interestingly, sampling time was a significant (P ¼ 0.005) variable for the apparent expression of efficacy in control tissues, which increased along time.
Gold Nanoparticles Distribution Within the Colon Wall Tissue
To reveal the physical limitations imposed by the tissue to the pass of particles as a function of their diameter, another colon segment was retrogradely injected at 20 mL/s with buffered 2.5% glutaraldehyde solution containing gold nanoparticles (10 12 particles per milliliter). The nanoparticle diameters used in this experiment were 4 and 15 nm (real diameters follow a Gaussian distribution). The gold nanoparticle distribution in the colon segment is shown in Figure 5 . No nanoparticles are observed inside the colon cells nuclei in any case, thus suggesting the restrictive physical barriers imposed by nuclear envelope to be crossed. Most of the small (4 nm) nanoparticles observed appeared within enterocytes' cytoplasm in the mucosa area (Fig. 5A, B) . In our hands, it was hard to detect any large 15 nm nanoparticles within a colon cell. The few large nanoparticles observed were present in the submucosal area (Fig. 5C ).
DISCUSSION
The local expression of IL10 protein in colon segments mediated by hydrodynamic gene transfer could be a useful tool for the treatment of different colonic pathologies, including Crohn's disease. In this work, we have demonstrated for the first time that this procedure efficiently delivers a human gene with clinical interest into the cells of human colon and that this gene is correctly transcribed and translated, achieving protein levels in tissue compatible with local immunosuppressant effects, as previously reported in human liver segments "ex vivo" and in pig heart "in vivo." [18] [19] [20] During the last years, the medical treatment of Crohn's disease has improved with the introduction of monoclonal antitumor necrosis factor antibodies. However, this new family of drugs is not exempt from important side effects and complications. Moreover, its efficacy is often limited by the development of antidrug antibodies and their economic cost is still high. 24 Despite these improvements, 80% of patients with Crohn's disease still need surgical treatment during their life for intestinal complications. 3, 4 Thus, new tools to set an efficient modulation of immune response are required. In this sense, gene therapy using genes that encode immunosuppressive proteins, as IL10, presents great interest that is worth being explored. IL10 is an optimal candidate because it presents the natural ability to modulate the immune response at different levels: converts naive T cells into Treg, inhibits the antigen presentation by major histocompatibility complex class II cells, and diminishes the expression of proinflammatory cytokines. Preclinical studies reported the benefits of IL10 in psoriasis 25 and IBD in mouse. 6,10 Thus, we aimed to test the potential benefit in human tissue to confirm its clinical interest.
IL10 local administration could avoid its undesirable systemic pleiotropic effects. Thus, gene therapy strategies based on locoregional delivery could offer advantages related to the stationary protein secretion circumscribed to the area of interest. Two types of vectors can be used for gene therapy but the nonviral ones have proved to be safer. Although viral vectors are more efficient, the low protein secretion required to mediate immune-modulatory effects makes nonviral vectors suitable for the purposes in the above-mentioned pathologies. In this sense, a good choice is the naked DNA delivery by hydrodynamic injection, which has demonstrated to be safe and therapeutically efficient in animal models and could currently be easily moved to the clinic. 15 Our aim in this work was to demonstrate that an efficient hydrodynamic procedure could be realistically implemented in the clinical setting. For this purpose, we first needed to demonstrate that the gene could be correctly delivered and efficiently expressed by the intestine cells in normal tissue proceeding from surgical resection for cancer. Moreover, there is a practical technical reason that justified our choice. When performing an intestinal resection for cancer, the vessels are divided close to the origin for oncologic reasons and are therefore of big diameter. This fact allows more easily the injection of the volume of solution needed for transfection experiments. However, when an intestinal resection for Crohn's disease is performed, usually the resection of the mesentery is performed close to the bowel and the vessels are therefore of small diameter, making the high flow rate of plasmid solution injection more difficult. The vein through which the plasmid is injected is not directly tributary to the tumor, thus tumor presence does not affect the solution distribution throughout the segment.
In this work, we show that human colon segments are efficiently transfected by this hydrodynamic procedure, achieving high levels of protein translation in tissue. The experiments were performed in human segments of colon "ex vivo" without clearance, and the molecular analyses were performed on tissue samples maintained in culture after gene transfer. The viability of these samples is limited to the 4 days reported. After that, the tissue may become highly degraded, and DNA and RNA purifications are inefficient and irregular. However, in our preliminary experiments in pig liver "in vivo" (data not shown), IL-10 overexpression lasts for, at least, 3 to 4-fold longer. The procedure demonstrated to be efficient for gene delivery with homogeneous distribution of the gene. This is an apparent index because it is not possible to know how homogeneous the distribution and bioavailability of the DNA within the tissue are. For this reason, to determine the transcription rate, we calculated the index of RNA transcription and we compared the results obtained versus nontransfected controls. The index of transcription was significantly higher in treated samples and similar throughout each colon specimen with no major differences between areas at different distance from the site of injection. Regarding DNA decrease over time, our hypothesis is that after DNA injection, only the molecules that arrive to the nucleus (bioavailable) will be transcribed efficiently and the index of transcription is steady. However, the nonbioavailable DNA (those molecules that did not reach the nucleus) that remains in the interstitial space, within endocytic vesicles or in the cytoplasm, will be degraded resulting in decreased levels of total DNA without affecting the transcription process of nuclear DNA. Regarding the tumor, because the tumor typically increased vessels permeability, we hypothesize that the DNA entry into the cells nuclei is more efficient and therefore there is less nonbioavailable DNA. Consequently, more stable total DNA levels are observed over time.
Then, to evaluate the efficiency of IL10 synthesis, we determined the protein quantity in tissue, achieving up to 1000 copies per cell, a high rate of protein translation considering that it is related to every cell. We cannot see anti-inflammatory effects on a normal tissue. These results will need validation in inflammatory tissues; however, in other preliminary experiments performed in our laboratory on pig liver "in vivo" (data not shown), we observed that similar indexes of tissue translation mediated plasma (in bloodstream) levels of up to 110 pg/mL. The reported EC50 of IL10 for tumor necrosis factor-alpha is 124 pg/mL. 7 Thus, we consider that the procedure produces an anti-inflammatory effect, especially considering that the presence of protein should be higher in the target area.
In our hands, the injection of 50 mL plasmid solution through a colic vein permitted transferring the gene to the entire ascendant or descendant segments. In larger transverse and sigmoid segments, the IL10 gene diffused efficiently, too. Considering that 50 mL permitted the diffusion of plasmid solution throughout each segment of colon, 200 mL of solution could diffuse throughout the entire organ but the injection should be performed in a more proximal vessel (superior and inferior mesenteric veins). However, the specific hydrodynamic conditions to transfect the particular segments of colon should be previously confirmed in large animals "in vivo" by surgical and/or cathetermediated procedures.
Because IBD is an appropriate candidate for the hydrodynamic procedure, we aimed to study its potential interest in this pathologic condition. Thus, we injected the hIL10 gene to 1 IBD specimen and performed the same molecular analyses performed in the other tumor-bearing segments. However, the conditions of injection had to be modified (25 mL volume at 10 mL/s) to preserve the habitual surgical practice (removal of reduced vascular pedicle) required by the Ethics Committee of our Hospital. DNA solution (20 mg/mL) was injected and after 5 minutes of incubation, different tissue samples (A, B, and untransfected control) were cultured and collected for molecular analyses. In untransfected control sample, we observed less than 1 copy per cell of RNA and 10 copies of protein per cell, respectively. However, the transfected samples yielded much higher expression of hIL10 RNA and mediated a slightly higher protein translation. In this sense, we quantified up to 640,000 copies of RNA at day 1 and it quickly stabilizes thereafter with approximately 1000 copies per cell during at last 4 days, which is similar to the obtained in normal tissue. Although the index of protein translation in IBD specimen was lower than the observed in normal tissue from tumor-bearing segments (due to the conditions of tissue and/or to the conditions of injection), we achieved up to 110 copies of protein per cell at day 2, 10-fold higher than in control untransfected sample. This preliminary experiment supports the potential interest of hydrodynamic gene delivery to human colon for IBD treatment especially considering that better results could be achieved by using the optimal hydrofection conditions. However, to evaluate the tissue natural barriers for gene transfer, trying to understand the molecular mechanisms of gene transfer, we injected a colon segment following the same protocol used with gene solution at 20 mL/s, but with gold nanoparticles instead of plasmid in the solution, and then observed histological samples under electron microscope. We hardly observed 15 nm particle inside the enterocytes, and they were only present in the submucosal area suggesting that a strict size limitation is imposed by membranes. However, we observed 4 nm particles within the cytoplasm of enterocytes without crossing the nuclear compartment. Although 4 nm nanoparticles cannot access the nucleus, plasmids with similar size reach it (the diameter of DNA molecule has been reported to be approximately 2 nm 22 ), as demonstrated by IL10 gene transcription. This supports the existence of an active mechanism of nucleic acids transportation into the nucleus although a passive diffusion cannot be discarded. Apart from intrinsic cell characteristics, the distribution of plasmid must be related with the hydric force exerted with the injection and the cells proximity to the sinusoidal vessel. In liver, with a more homogeneous structure than the colon, a differential distribution of the injected plasmid has been reported. 26 In summary, this work shows for the first time that hydrodynamic procedure efficiently delivers the IL10 gene to the human colon, achieving indexes of tissue protein expression that could mediate pharmacological effects with interest in controlling the immune response triggered in patients with Crohn's disease. Besides, the described model of hydrodynamic gene transfer to human colon segments and the molecular evaluation of its decoding process permits studying the efficacy of any gene with clinical interest and foresees its efficacy in humans "in vivo" as the step before clinical onset of hydrodynamic gene therapy in humans. Further studies using tagged human genes, to differentiate endogenous from exogenous genes, in "ex vivo" human colon segments will permit evaluating the entire process of gene decoding, from delivery to protein secretion.
